Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 230 results for "Acute Myeloid Leukemia (AML)".

Thumbnail for Molecular Subtype-Specific Risk of Subsequent Acute Myeloid Leukemia Following Breast Cancer: A Population-Based SEER Analysis

AML - 1464

Molecular Subtype-Specific Risk of Subsequent Acute Myeloid Leukemia Following Breast Cancer: A Population-Based SEER Analysis

Maryam Ali

Poster Presenter: Maryam Ali

Thumbnail for Defining the “Frailty Cliff": A Restricted Cubic Spline Meta-Analysis of AI-Derived Continuous Mesenteric Adiposity and Skeletal Muscle Index on Induction Mortality in Acute Myeloid Leukemia

AML - 1473

Defining the “Frailty Cliff": A Restricted Cubic Spline Meta-Analysis of AI-Derived Continuous Mesenteric Adiposity and Skeletal Muscle Index on Induction Mortality in Acute Myeloid Leukemia

Iman Khan

Poster Presenter: Iman Khan

Previous 1...7 8 9 10 11 12 13...26 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Lower-Intensity Versus Intensive Therapy in Older Adults With Newly Diagnosed AML: A Systematic Review and Meta-Analysis

AML - 1475

Lower-Intensity Versus Intensive Therapy in Older Adults With Newly Diagnosed AML: A Systematic Review and Meta-Analysis

Musa Kiyani

Poster Presenter: Musa Kiyani

Thumbnail for Differential Impact of Allogeneic Stem Cell Transplantation by TP53 Mutational Status in High-Risk Myeloid Neoplasms With Complex or Monosomal Karyotype

AML - 1476

Differential Impact of Allogeneic Stem Cell Transplantation by TP53 Mutational Status in High-Risk Myeloid Neoplasms With Complex or Monosomal Karyotype

Paloma Resende

Poster Presenter: Paloma Resende

Thumbnail for Early Cytarabine Escalation Does Not Improve Short-Term Outcomes Compared With Hydroxyurea-Only Cytoreduction in Hyperleukocytic Acute Myeloid Leukemia: A Real-World Propensity-Matched Analysis

AML - 1478

Early Cytarabine Escalation Does Not Improve Short-Term Outcomes Compared With Hydroxyurea-Only Cytoreduction in Hyperleukocytic Acute Myeloid Leukemia: A Real-World Propensity-Matched Analysis

Akshay Aluri

Poster Presenter: Akshay Aluri

Thumbnail for Multi-Hit TET2 Inactivation Identifies a High-Risk Subgroup Assigned to Favorable or Intermediate Categories by the HARMONY Framework in NPM1-Mutated AML

AML - 1483

Multi-Hit TET2 Inactivation Identifies a High-Risk Subgroup Assigned to Favorable or Intermediate Categories by the HARMONY Framework in NPM1-Mutated AML

Paloma Resende

Poster Presenter: Paloma Resende

Thumbnail for Temporal Decline in Early Mortality in Acute Myeloid Leukemia Across Chemotherapy, Hypomethylating Agent, and Venetoclax-Based Therapeutic Eras: A Four-Decade Population-Based Analysis

AML - 1492

Temporal Decline in Early Mortality in Acute Myeloid Leukemia Across Chemotherapy, Hypomethylating Agent, and Venetoclax-Based Therapeutic Eras: A Four-Decade Population-Based Analysis

Shahzaib Maqbool

Poster Presenter: Shahzaib Maqbool

Thumbnail for CRISPR/Cas9-Mediated SHP2 Knockout in Jurkat T Cells Using Neon and MaxCyte Electroporation Platforms: Establishment and Validation of a Model for SHP2-Driven Resistance Mechanisms

AML - 150

CRISPR/Cas9-Mediated SHP2 Knockout in Jurkat T Cells Using Neon and MaxCyte Electroporation Platforms: Establishment and Validation of a Model for SHP2-Driven Resistance Mechanisms

Kashif Ali

Poster Presenter: Kashif Ali

Thumbnail for Age-, Sex-, Race-, and Ethnicity-Dependent Architecture of the AML DriverMutational Landscape: A Real-World Analysis of 5,111 Patients in AACRProject GENIE v18.0

AML - 1509

Age-, Sex-, Race-, and Ethnicity-Dependent Architecture of the AML DriverMutational Landscape: A Real-World Analysis of 5,111 Patients in AACRProject GENIE v18.0

Nency Ganatra

Poster Presenter: Nency Ganatra

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors